Table 7

Availability of medicine surveyed in different versions in private sector
OB HPG LPG
Medicine name, strength Medicine list Retail* Chain# Retail* Chain# Retail* Chain#
and dosage form Retail* (n = 40) (n = 40) (n = 40) (n = 40) (n = 40) (n = 40)
Amitriptyline 25 mg cap/tab Global 65.0% 80.0% 2.5% 0.0% 12.5% 12.5%
Amlodipine 5 mg cap/tab Regional 52.5% 60.0% 82.5% 90.0% 95.0% 100.0%
Amoxicillin+clavulanic acid 500 mg+125 mg cap/tab Supplementary NS** NS 95.0% 100.0% 100.0% 100.0%
Amoxicillin 500 mg cap/tab Global 0.0% 0.0% 95.0% 92.5% 97.5% 100.0%
Amoxicillin 250 mf cap/tab Supplementary NS NS 72.5% 97.5% 92.5% 100.0%
Amoxicillin suspension 25 mg/ml Regional 0.0% 0.0% 57.5% 70.0% 95.0% 92.5%
Amoxicillin+clavulanic acid Syrup 200 mg+28.5 mg/5 ml Supplementary NS NS 62.5% 90.0% 92.5% 92.5%
Ampicillin Suspension 125 mg/5 ml Supplementary NS NS 2.5% 0.0% 2.5% 0.0%
Atenolol 50 mg cap/tab Global 45.0% 45.0% 67.5% 92.5% 97.5% 100.0%
Atorvastatin 10 mg cap/tab Regional 12.5% 30.0% 87.5% 85.0% 97.5% 95.0%
Azithromycin 500 mg cap/tab Supplementary NS NS 95.0% 97.5% 100.0% 100.0%
Beclomethasone inhaler 250 mcg/dose Regional 5.0% 0.0% 0.0% 0.0% 35.0% 37.5%
Benzathine Penicillin Powder 2.4 MU/vial Supplementary NS NS 0.0% 0.0% 0.0% 0.0%
Budesonide inhaler 100 mcg/dose Supplementary NS NS 7.5% 10.0% 62.5% 82.5%
Budesonide+Formoterol inhaler 100 mcg+6mcg/dose Supplementary NS NS 0.0% 0.0% 42.5% 27.5%
Captopril 25 mg cap/tab Global 0.0% 0.0% 0.0% 0.0% 10.0% 10.0%
Cefixime 200 mg cap/tab Supplementary NS NS 80.0% 95.0% 97.5% 100.0%
Ceftriaxone injection 1 g/vial Global 0.0% 0.0% 2.5% 5.0% 47.5% 42.5%
Cefuroxime axetil 250 mg cap/tab Supplementary NS NS 55.0% 60.0% 90.0% 100.0%
Cefuroxime Suspension 125 mg/5 ml Supplementary NS NS 2.5% 0.0% 55.0% 50.0%
Cephalexin 500 mg cap/tab Supplementary NS NS 32.5% 30.0% 65.0% 80.0%
Cephalexin Syrup 250 mg/5 ml Supplementary NS NS 22.5% 22.5% 50.0% 40.0%
Ciprofloxacin 500 mg cap/tab Global 0.0% 0.0% 85.0% 92.5% 100.0% 100.0%
Clotrimazole topical cream 1% Regional 50.0% 55.0% 10.0% 17.5% 50.0% 67.5%
Co-trimoxazole suspension 8+40 mg/ml Global 5.0% 10.0% 0.0% 0.0% 77.5% 67.5%
Diazepam 5 mg cap/tab Global 35.0% 52.5% 5.0% 2.5% 37.5% 57.5%
Diclofenac 50 mg cap/tab Global 97.5% 97.5% 10.0% 12.5% 65.0% 82.5%
Diethylcarbamazine citrate 50 mg cap/tab Regional 12.5% 10.0% 0.0% 0.0% 10.0% 10.0%
Doxycycline 100 mg cap/tab Regional 0.0% 0.0% 55.0% 60.0% 97.5% 95.0%
Enalapril 5 mg cap/tab Regional 0.0% 0.0% 42.5% 32.5% 92.5% 97.5%
Erythromycin powder for suspension 125 mg/5 ml Supplementary NS NS 15.0% 15.0% 55.0% 55.0%
Erythromycin Stearate 250 mg cap/tab Supplementary NS NS 35.0% 25.0% 82.5% 85.0%
Fluoxetine 20 mg cap/tab Regional 0.0% 0.0% 42.5% 62.5% 80.0% 92.5%
Gentamicin eye drops 0.3% Regional 5.0% 2.5% 2.5% 0.0% 65.0% 50.0%
Gentamicin injection 40 mg/ml Supplementary NS NS 15.0% 17.5% 57.5% 50.0%
Glibenclamide 5 mg cap/tab Global 65.0% 72.5% 0.0% 0.0% 5.0% 7.5%
Gliclazide 80 mg cap/tab Regional 0.0% 2.5% 55.0% 67.5% 95.0% 97.5%
Ibuprofen 400 mg cap/tab Regional 95.0% 82.5% 0.0% 0.0% 45.0% 40.0%
Metformin 500 mg cap/tab Regional 0.0% 0.0% 82.5% 80.0% 97.5% 95.0%
Metronidazole 400 mg cap/tab Regional 45.0% 52.5% 2.5% 5.0% 92.5% 95.0%
Norfloxacin 400 mg cap/tab Supplementary NS NS 5.0% 0.0% 95.0% 97.5%
Ofloxacin 200 mg cap/tab Supplementary NS NS 92.5% 97.5% 97.5% 100.0%
Omeprazole 20 mg cap/tab Global 0.0% 0.0% 87.5% 95.0% 100.0% 100.0%
Paracetamol suspension 24 mg/ml Global 62.5% 65.0% 20.0% 17.5% 90.0% 97.5%
Phenytoin 100 mg cap/tab Regional 37.5% 45.0% 32.5% 40.0% 90.0% 95.0%
Ranitidine 150 mg cap/tab Regional 95.0% 85.0% 82.5% 87.5% 97.5% 95.0%
Roxithromycin 50 mg cap/tab Supplementary NS NS 17.5% 25.0% 92.5% 97.5%
Salbutamol inhaler 100 mcg/dose Global 52.5% 45.0% 7.5% 7.5% 92.5% 95.0%
Simvastatin 20 mg cap/tab Global 42.5% 42.5% 2.5% 0.0% 40.0% 35.0%
Zinc sulphate dispersible 20 mg cap/tab Supplementary NS NS 0.0% 0.0% 0.0% 2.5%

*Retail indicates the retail pharmacies shops and #Chain indicates retail chain pharmacies.

OB – Originator Brand.

HPG – Highest priced generic.

LPG – Lowest priced generic.

**NS – Not surveyed.

Kotwani

Kotwani BMC Health Services Research 2013 13:285   doi:10.1186/1472-6963-13-285

Open Data